Chapel Hill, NC2 Active Studies

Chronic Kidney Disease Clinical Trials in Chapel Hill, NC

Find 2 actively recruiting chronic kidney disease clinical trials in Chapel Hill, NC. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
1,360
Enrolling

Recruiting Chronic Kidney Disease Studies in Chapel Hill

About Chronic Kidney Disease Clinical Trials in Chapel Hill

Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.

There are currently 2 chronic kidney disease clinical trials recruiting participants in Chapel Hill, NC. These studies are seeking a combined 1,360 participants. Research is being sponsored by Icahn School of Medicine at Mount Sinai, University of Pennsylvania. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Kidney Disease Clinical Trials in Chapel Hill — FAQ

Are there chronic kidney disease clinical trials in Chapel Hill?

Yes, there are 2 chronic kidney disease clinical trials currently recruiting in Chapel Hill, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chapel Hill?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.

Are clinical trials in Chapel Hill free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.

What chronic kidney disease treatments are being tested?

The 2 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for chronic kidney disease.

Data updated July 18, 2026 from ClinicalTrials.gov